ChemicalBook >> CAS DataBase List >>GSK461364

GSK461364

CAS No.
929095-18-1
Chemical Name:
GSK461364
Synonyms
CS-553;GSK4613;GSK461364;GSK-461364;GSK-461364A;GSK461364 USP/EP/BP;GSK461364(GSK-461364);GSK-461364; GSK-461364A;PLK1 inhibitor GS461364;PLK1 inhibitor GSK461364
CBNumber:
CB62473747
Molecular Formula:
C27H28F3N5O2S
Molecular Weight:
543.6
MDL Number:
MFCD12755419
MOL File:
929095-18-1.mol
MSDS File:
SDS
Last updated:2023-05-18 11:31:19

GSK461364 Properties

Melting point >150°C (dec.)
Boiling point 658.0±65.0 °C(Predicted)
Density 1.39
storage temp. Hygroscopic, -20°C Freezer, Under inert atmosphere
solubility Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
pka 15.16±0.50(Predicted)
form Solid
color Off-White to Light Beige
FDA UNII 8QO27TK6Q4

GSK461364 price More Price(29)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 18099 GSK461364 ≥95% 929095-18-1 1mg $34 2024-03-01 Buy
Cayman Chemical 18099 GSK461364 ≥95% 929095-18-1 5mg $117 2024-03-01 Buy
Cayman Chemical 18099 GSK461364 ≥95% 929095-18-1 10mg $216 2024-03-01 Buy
Cayman Chemical 18099 GSK461364 ≥95% 929095-18-1 25mg $493 2024-03-01 Buy
TRC G797705 GSK461364 929095-18-1 2.5mg $50 2021-12-16 Buy
Product number Packaging Price Buy
18099 1mg $34 Buy
18099 5mg $117 Buy
18099 10mg $216 Buy
18099 25mg $493 Buy
G797705 2.5mg $50 Buy

GSK461364 Chemical Properties,Uses,Production

Uses

GSK 461364 is a dose-dependant inhibitor of proliferating cancer cell lines as well as an apoptotic agent at higher dosage levels.

Definition

ChEBI: 5-[6-[(4-methyl-1-piperazinyl)methyl]-1-benzimidazolyl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide is a member of (trifluoromethyl)benzenes.

Biological Activity

gsk461364 is a potent and reversible atp competitive plk1 inhibitor. polo-like kinases (plk) are a family of serine threonine kinases that are critical regulators of dna damage response and cell cycle progression.

in vitro

gsk461364 showed at least 390-fold greater selectivity for plk1 than for plk2 and plk3 and 1,000-fold greater than for 48 other kinases. the drug showed antiproliferative activity against multiple (>120) tumor cell lines and potently inhibited the proliferation of greater than 83% and 91% of these cell lines [1].

in vivo

intraperitoneal administration of gsk461364 caused regression or tumor growth delay in different xenograft models. in vivo suppression of plk1 by using gsk461364 resulted in mitotic arrest with aberrant mitotic figures consisting of monopolar or collapsed mitotic spindles [1].

target

PLK1

References

[1] olmos d, barker d, sharma r, brunetto at, yap ta, taegtmeyer ab, barriuso j, medani h, degenhardt yy, allred aj, smith da, murray sc, lampkin ta, dar mm, wilson r, de bono js, blagden sp. phase i study of gsk461364, a specific and competitive polo-like kinase 1 inhibitor, in patients with advanced solid malignancies. clin cancer res. 2011 may 15;17(10):3420-30.

GSK461364 Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 115)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 32480 60
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22968 58
BOC Sciences
+1-631-485-4226 inquiry@bocsci.com United States 19553 58
Alchem Pharmtech,Inc.
8485655694 sales@alchempharmtech.com United States 63711 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49390 58
career henan chemical co
+86-0371-86658258 15093356674; factory@coreychem.com China 29826 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626 eric@witopchemical.com China 23556 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 29016 58
Finetech Industry Limited
+86-27-87465837 +8618971612321 info@finetechnology-ind.com China 9633 58
Hefei Hirisun Pharmatech Co., Ltd
+8615056975894 shawn@hirisunpharm.com CHINA 9923 58

View Lastest Price from GSK461364 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
GSK-461364 pictures 2020-01-13 GSK-461364
929095-18-1
US $1.00 / g 1g 99% 1ton Career Henan Chemical Co
  • GSK-461364 pictures
  • GSK-461364
    929095-18-1
  • US $1.00 / g
  • 99%
  • Career Henan Chemical Co

GSK461364 Spectrum

(R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide GSK-461364A GSK461364(GSK-461364) 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl] 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phen GSK461364 GSK-461364 GSK4613 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide GSK461364, 98%, a potent Polo-like kinase 1 (PLK1) inhibitor GSK-461364; GSK-461364A PLK1 inhibitor GS461364 CS-553 2-Thiophenecarboxamide, 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]- GSK461364 USP/EP/BP PLK1 inhibitor GSK461364 5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide 929095-18-1 C27H28F3N5O2S Inhibitors APIs